Hammerman; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hammerman; Peter.The latest application filed is for "combination therapy of transcription inhibitors and kinase inhibitors".

Company Profile

6.3.8

Hammerman; Peter - Newton MA
Hammerman; Peter - Boston MA
Hammerman; Peter - Jamaica Plain MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors App 20200338074 - Hammerman; Peter ; et al.	2020-10-29
Combination therapy of transcription inhibitors and kinase inhibitors Grant 10,702,527 - Hammerman , et al.	2020-07-07
Compositions And Methods For Identification, Assessment, Prevention, And Treatment Of Cancer Using Pd-l1 Isoforms App 20200095644 - Hammerman; Peter ; et al.	2020-03-26
DDR2 Mutations in Squamous Cell Lung Cancer App 20200087734 - Meyerson; Matthew ; et al.	2020-03-19
DDR2 mutations in squamous cell lung cancer Grant 10,385,403 - Meyerson , et al. A	2019-08-20
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors App 20190015411 - Hammerman; Peter ; et al.	2019-01-17
Combination Therapy Of Transcription Inhibitors And Kinase Inhibitors App 20180169097 - Hammerman; Peter ; et al.	2018-06-21
DDR2 Mutations in Squamous Cell Lung Cancer App 20170029903 - Meyerson; Matthew ; et al.	2017-02-02
DDR2 mutations in squamous cell lung cancer Grant 9,499,856 - Meyerson , et al. November 22, 2	2016-11-22
Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 Isoforms App 20160122829 - Hammerman; Peter	2016-05-05
DDR2 Mutations in Squamous Cell Lung Cancer App 20130261017 - Meyerson; Matthew ; et al.	2013-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.